Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teng-Yu Lee

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Gastroenterology|October 8, 2015
The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort StudyTeng-Yu Lee, Ren-Ching Wang, Yi-Chia Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 2, 2014
A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohortTeng-Yu Lee, Chang-Bi Wang, Tzu-Ting Chen, et al.
JAMA Internal Medicine|March 19, 2019
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis BTeng-Yu Lee, Yao-Chun Hsu, Hsiao-Ching Tseng, et al.
Hepatology International|July 24, 2015
A nationwide population-based study shows increasing incidence of cholangiocarcinomaTeng-Yu Lee, Jaw-Town Lin, Ken N Kuo, et al.
International Journal of Cancer|November 7, 2012
Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trialYoung-Hwa Chung, Guohong Han, Jung-Hwan Yoon, et al.
International Journal of Cancer|August 8, 2014
The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trialYee Chao, Young-Hwa Chung, Guohong Han, et al.
Gastroenterology|April 8, 2014
Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort studyChun-Ying Wu, Jaw-Town Lin, Hsiu J Ho, et al.
International Journal of Surgery (London, England)|July 23, 2024
Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and bibliometric analysisChun-Ying Wu, Lee-Yuan Lin, Teng-Yu Lee, et al.
Journal of Gastroenterology and Hepatology|September 9, 2021
Establishing the blood reference interval of pancreatic elastase-1: A prospective studySu-Fen Chi, Chia-Yeh Lai, Wei-Ting Dong, et al.
Cancers|September 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on ImmunotherapyShou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Gastroenterology|October 8, 2015
The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort StudyTeng-Yu Lee, Ren-Ching Wang, Yi-Chia Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 2, 2014
A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohortTeng-Yu Lee, Chang-Bi Wang, Tzu-Ting Chen, et al.
JAMA Internal Medicine|March 19, 2019
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis BTeng-Yu Lee, Yao-Chun Hsu, Hsiao-Ching Tseng, et al.
Hepatology International|July 24, 2015
A nationwide population-based study shows increasing incidence of cholangiocarcinomaTeng-Yu Lee, Jaw-Town Lin, Ken N Kuo, et al.
International Journal of Cancer|November 7, 2012
Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trialYoung-Hwa Chung, Guohong Han, Jung-Hwan Yoon, et al.
International Journal of Cancer|August 8, 2014
The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trialYee Chao, Young-Hwa Chung, Guohong Han, et al.
Gastroenterology|April 8, 2014
Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort studyChun-Ying Wu, Jaw-Town Lin, Hsiu J Ho, et al.
International Journal of Surgery (London, England)|July 23, 2024
Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and bibliometric analysisChun-Ying Wu, Lee-Yuan Lin, Teng-Yu Lee, et al.
Journal of Gastroenterology and Hepatology|September 9, 2021
Establishing the blood reference interval of pancreatic elastase-1: A prospective studySu-Fen Chi, Chia-Yeh Lai, Wei-Ting Dong, et al.
Cancers|September 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on ImmunotherapyShou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, et al.
Pageof 13